Get the Stockscreener App
5.75
11.87%
0.61
After Hours:
5.73
-0.02
-0.35%
Bionano Genomics Inc stock is traded at $5.75, with a volume of 386.00K.
It is up +11.87% in the last 24 hours and down -66.50% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
See More
Previous Close:
$5.14
Open:
$5.04
24h Volume:
386.00K
Relative Volume:
2.42
Market Cap:
$13.40M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.3234
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
-27.56%
1M Performance:
-66.50%
6M Performance:
-84.75%
1Y Performance:
-92.33%
1-Day Range:
$5.04
$5.8499
1-Week Range:
$4.95
$7.98
52-Week Range:
$4.95
$81.00
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
5.75 | 13.40M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
580.18 | 206.65B | 8.35B | 2.32B | 586.00M | 6.41 |
|
BDX
Becton Dickinson Co
|
248.49 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
92.32 | 45.66B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
257.65 | 37.85B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
343.91 | 24.95B | 2.88B | 499.60M | 321.60M | 6.74 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Bionano Genomics (NASDAQ:BNGO) Trading Up 5.5%Still a Buy? - MarketBeat
BioNano Genomics Executes Significant Reverse Stock Split - MSN
Bionano Genomics (NASDAQ:BNGO) Shares Gap DownTime to Sell? - MarketBeat
Bionano Genomics (NASDAQ:BNGO) Hits New 52-Week LowHere's Why - MarketBeat
Bionano Genomics stock hits 52-week low at $0.17 amid market challenges - MSN
Bionano Genomics stock hits 52-week low at $0.17 amid market challenges By Investing.com - Investing.com South Africa
Bionano Genomics announces 1-for-60 reverse stock split - MSN
Bionano Genomics stock slips on reverse stock split (BNGO) - Seeking Alpha
Bionano Announces Effective Date of Reverse Stock Split - The Manila Times
Bionano Genomics shareholders approve stock issuance and reverse split - Investing.com India
Bionano Genomics shareholders approve stock issuance and reverse split By Investing.com - Investing.com UK
Bionano Genomics, Inc. Announces Use of Ogm in Preimplantation Genetic Testing as Part of Successful Live Birth to A Couple Experiencing Recurrent Pregnancy Loss - Marketscreener.com
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss - The Manila Times
Bionano reports Q4 preliminary revenue in range of $7.9 million to $8.1 million - MSN
Bionano Genomics, Inc. Provides Earnings Guidance for the Fourth Quarter and for Full Year 2024 - Marketscreener.com
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results - The Manila Times
Bionano Genomics, Inc. (NASDAQ:BNGO) Position Raised by Geode Capital Management LLC - Defense World
Bionano Genomics Announces $10 Million Registered Direct OfferingOn January 3, 2025, Bionano Genomics, Inc. (NASDAQ: BNGO) disclosed a definitive agreement with institutional investors for a registered direct offering. The offering involves the purch - Defense World
What You Didn’t Know About Bionano Genomics Inc (NASDAQ: BNGO) This Week - Stocks Register
BioNano Genomics Announces $10 Million Direct Offering - Yahoo Finance
Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano announces registered direct offering - Medical Buyer
Bionano Genomics Restructures Debt Through Settlement Agreement and AmendmentSAN DIEGO, December 31, 2024 – Bionano Genomics, Inc. (Nasdaq: BNGO) has announced the execution of a settlement agreement and amendment concerning its senio - Defense World
Bionano stock rallies 19% on ATM direct offering - MSN
Bionano Genomics Announces Registered Direct Stock Offering to Raise $10 Million - Marketscreener.com
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - GlobeNewswire Inc.
BioNano Genomics, Inc. Files for 50.56M Share Offering by Selling Stockholders - Investing.com South Africa
BNGO (Bionano Genomics) Earnings per Share (Diluted) : $-4.46 (TTM As of Sep. 2024) - GuruFocus.com
Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway - The Manila Times
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail
DJ All Cattle Index (BAC) QuotePress Release - The Globe and Mail
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Bayer Aktienges ADR (BAYRY) QuotePress Release - The Globe and Mail
Pfizer Inc (PFE-N) QuotePress Release - The Globe and Mail
Senior Loan Invesco ETF (BKLN-A) QuotePress Release - The Globe and Mail
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis - The Manila Times
Bionano's Groundbreaking Study: Optical Genome Mapping Achieves 100% Detection Rate in Cancer Analysis - StockTitan
Bionano Genomics stock hits 52-week low at $0.2 amid market challenges - Investing.com India
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal - The Manila Times
Bionano Genomics Issues Critical Stockholder Letter Ahead of Special Meeting - StockTitan
Bionano Genomics (NASDAQ:BNGO) Shares Down 6% – What’s Next? - Defense World
Bionano Genomics, Inc. (NASDAQ:BNGO) Might Not Be As Mispriced As It Looks - Simply Wall St
Uber Technologies Inc (UBER-N) QuotePress Release - The Globe and Mail
Bionano Genomics announces presentations at ASH annual meeting - Nasdaq
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy - The Manila Times
Bionano Genomics Showcases Breakthrough OGM Technology Across 13 Cancer Research Studies at ASH 2024 - StockTitan
Tractor Supply Company (TSCO-Q) QuotePress Release - The Globe and Mail
Bionano Genomics (STU:2Y30) Current Ratio : 1.43 (As of Sep. 2024) - GuruFocus.com
Bionano Genomics shareholders approve warrant share issuance By Investing.com - Investing.com Nigeria
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):